Recurrent Soft Tissue Sarcoma Recruiting Phase 1 Trials for 7-ethyl-10-hydroxycamptothecin (DB05482)

IndicationStatusPhase
DBCOND0105100 (Recurrent Soft Tissue Sarcoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04619056First-in-man Clinical Trial of CEB-01 PLGA Membrane in Recurrent or Locally Advanced Retroperitoneal Soft Tissue SarcomaTreatment